Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2011-06-28
2011-06-28
Minnifield, N. M (Department: 1645)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
Reexamination Certificate
active
07968297
ABSTRACT:
Described is a method for identification, isolation and production of hyperimmune serum-reactive antigens from a specific pathogen, a tumor, an allergen or a tissue or host prone to autoimmunity, said antigens being suited for use in a vaccine for a given type of animal or for humans, which is characterized by the following steps: —providing an antibody preparation from a plasma pool of said given type of animal or from a human plasma pool or individual sera with antibodies against said specific pathogen, tumor, allergen or tissue or host prone to auto-immunity, —providing at least one expression library of said specific pathogen, tumor, allergen or tissue or host prone to auto-immunity, —screening said at least one expression library with said antibody preparation, —identifying antigens which bind in said screening to antibodies in said antibody preparation, —screening the identified antigens with individual antibody preparations from individual sera from individuals with antibodies against said specific pathogen, tumor, allergen or tissue or host prone to auto-immunity, —identifying the hyperimmune serum-reactive antigen portion of said identified antigens and which hyperimmune serum-reactive antigens bind to a relevant portion of said individual antibody preparations from said individual sera and —optionally isolating said hyperimmune serum-reactive antigens and producing said hyperimmune serum-reactive antigens by chemical or recombinant methods.
REFERENCES:
patent: 5980908 (1999-11-01), Hook et al.
patent: 0786519 (1997-07-01), None
patent: WO 9957312 (1999-11-01), None
patent: WO 99/67376 (1999-12-01), None
patent: WO 00/45839 (2000-08-01), None
patent: WO 00/56357 (2000-09-01), None
patent: WO 00/68373 (2000-11-01), None
patent: WO 01/70955 (2001-09-01), None
patent: WO 01/98499 (2001-12-01), None
patent: WO 02/077183 (2002-10-01), None
patent: WO 02/094868 (2002-11-01), None
patent: WO 02/102829 (2002-12-01), None
patent: WO 03/011899 (2003-02-01), None
patent: WO 2005/009379 (2005-02-01), None
Aldrich Catalog, 1994, Aldrich Chemical Company, Inc.
Greenspan et al. (Nature Biotechnology 7: 936-937, 1999).
Kaeberlein et al., Science, 296:1127-1129, 2002).
Bowie et al (Science, 1990, 247:1306-1310).
Bleul et al. (J. Clin. Microbiol., 29:1579-1588, 1991).
Staats et al. (J. Immunol., 157:462-472, 1996).
Cortese et al. (Trends in Biotech., 12:262-267, 1994).
Handfield et al. (Trends Microbiol., 8:336-339, 2000).
Georgiou et al., “Display of heterologous proteins on the surface of microorganisms: From the screening of combinatorial libraries to live recombinant vaccines,”Nature Biotechnology, 15:29-34, 1997.
Kuroda et al., “Whole genome sequencing of meticillin-resistantStaphylococcus aureus,” Lancet, 357:1225-1240, 2001.
Mazmanian et al., “Sortase-catalysed anchoring of surface proteins to the cell wall ofStaphylococcus aureus,” Mol. Microbiol., 40:1049-1057, 2001.
Barbet, “Vaccines and molecular biology,”Veterinary Molecular Biology, Chapter 10, http://parasite.arf.ufl.edu/path/teach/vem1531/publish/ve0018.htm (east Update Apr. 21, 1998).
Burnie et al., “Identification of an immunodominant ABC transporter in methicillin-resistantStaphylococcus aureusinfections,”Infect. Immun., 68(6):3200-3209, 2000.
Casolini et al., “Antibody response to fibronectin-binding adhesin FnbpA in patients withStaphylococcus aureusinfections,”Infection and Immunity, 66(11):5433-5442, 1998.
Etz et al., “Identification of in vivo expressed vaccine candidate antigens fromStaphylococcus aureus,” PNAS, 99(10):6573-6578, 2002.
Gliden et al., “Molecular immunologic strategies to identify antigens and B-cell responses unique to multiple sclerosis,”Arch Neurol., 58(1):43-48, 2001.
Kuroda et al., “Staphylococcus aureushypothetical protein SA1522,” SWALL, Accession No. Q99TD3, 2001.
Kuroda et al., “Staphylococcus aureushypothetical protein SAV1129,” SWALL, Accession No. Q99UX5, 2001.
Kuroda et al., “Staphylococcus aureushypothetical protein SAV1731,” SWALL, Accession No. Q931P4, 2001.
Ortega-Mora et al., “Identification of cryptosporidium parvum oocyct/sprozoite antigens recognized by infected and hyperimmune lambs,”Veterinary parasitology, 53:159-166, 1994.
Sioud et al., “Profiling the immune responses in patient sera with peptide and cDNA display libraries(review),”International Journal of Molecular Medicine, 6(2):123-128, 2000.
Wang et al., “Use of a gene-targeted phage display random epitope library to map an antigenic determinant on the blue tongue virus outer capsid protein VP5.”Journal of Immunological Methods, 178(1):1-12, 1995.
Davis and Benzer, “Generation of cDNA expression libraries enriched for in-frame sequences,”Proc. Natl. Acad. Sci. USA, 94:2128-2132, 1997.
Hashemzadeh-Bonehi et al., “MicroCorrespondence—Importance of usinglacrather thanarapromoter vectors for modulating the levels of toxic gene products inEscherichia coli,” Molecular Microbiology, 30(3):673-678, 1998.
Skerra, “Use of the tetracycline promoter for the tightly regulated production of a murine antibody fragment inEscherichia coli,” Gene, 151:131-135, 1994.
Etz et al., “Bacterial phage receptors, versatile tools for display of polypeptides on the cell surface,”Journal of Bacteriology, 183(23):6924-6935, 2001.
Dryla Agnieszka
Etz Hildegard
Fraser Claire M.
Gill Steven
Hafner Martin
Gangle Brian J
Intercell AG
Minnifield N. M
Wolf Greenfield & Sacks P.C.
LandOfFree
Method for identification, isolation and production of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for identification, isolation and production of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for identification, isolation and production of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2738803